# Data‐Driven Implementation Trials: Realizing Their Full Potential in Achieving the Promise of Learning Health Systems

**Authors:** Charis X. Xie, Patricia D. Franklin, Theresa L. Walunas, Rinad S. Beidas

PMC · DOI: 10.1002/lrh2.70043 · Learning Health Systems · 2025-10-19

## TL;DR

This paper discusses how data-driven implementation trials can help transform healthcare systems by enabling scalable, evidence-based improvements.

## Contribution

The paper introduces actionable recommendations for optimizing data-driven implementation trials to support learning health systems.

## Key findings

- Data-driven implementation trials provide causal evidence for health system decision-making.
- Integration of implementation science supports scalable and equitable healthcare innovation.
- Collaboration and infrastructure improvements are critical for successful implementation.

## Abstract

The digital transformation of healthcare has generated unprecedented volumes of routine clinical data, enabling health system leaders, including quality improvement (QI) efforts, to optimize care using real‐time analytics. However, health system QI typically focuses on changes within localized environments; it is often limited in its ability to address systemic barriers or scale evidence‐based strategies across diverse settings. Thoughtful integration of implementation science (IS) approaches addresses this gap by systematically integrating interventions into diverse practice settings and defining generalizable implementation strategies. These attributes position IS as a cornerstone of learning health systems (LHS), which strive for population‐wide improvements through continuous, data‐driven learning. Within this paradigm, randomized implementation trials provide the gold standard for comparing and optimizing implementation strategies. By leveraging routine data, these trials generate causal evidence on the effectiveness of different approaches and offer rigorous insights for health system decision‐makers. In this viewpoint, we highlight data‐driven implementation trials as catalysts for rigorous and scalable health system transformation. Specifically, we articulate the value proposition of data‐driven implementation trials, examine their transformative potential toward learning health systems, and outline persistent challenges. Drawing on experiences from the UK and the US in large health systems, we propose actionable recommendations to optimize infrastructure, foster collaboration, secure health system‐level commitments, and cultivate a culture that is grounded in IS while augmenting the impact of QI—critical steps toward realizing scalable, equitable healthcare innovation.

## Full-text entities

- **Diseases:** Asthma (MESH:D001249), behavioral health disorders (MESH:D001523), influenza (MESH:D007251), acute pulmonary embolism (MESH:D011655), fatigue (MESH:D005221), COVID-19 (MESH:D000086382), long-term condition (MESH:D000088562), chronic disease (MESH:D002908)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12805805/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12805805/full.md

---
Source: https://tomesphere.com/paper/PMC12805805